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Abstract
Background: Expression of recombinant proteins in green algal chloroplast holds substantial
promise as a platform for the production of human therapeutic proteins. A number of proteins
have been expressed in the chloroplast of Chlamydomonas reinhardtii, including complex mammalian
proteins, but many of these proteins accumulate to significantly lower levels than do endogenous
chloroplast proteins. We examined if recombinant protein accumulation could be enhanced by
genetically fusing the recombinant reporter protein, luciferase, to the carboxy-terminal end of an
abundant endogenous protein, the large subunit of ribulose bisphosphate carboxylase (Rubisco
LSU). Additionally, as recombinant proteins fused to endogenous proteins are of little clinical or
commercial value, we explored the possibility of engineering our recombinant protein to be
cleavable from the endogenous protein in vivo. This strategy would obviate the need for further in
vitro processing steps in order to produce the desired recombinant protein. To achieve this, a
native protein-processing site from preferredoxin (preFd) was placed between the Rubisco LSU and
luciferase coding regions in the fusion protein construct.
Results: The luciferase from the fusion protein accumulated to significantly higher levels than
luciferase expressed alone. By eliminating the endogenous Rubisco large subunit gene (rbcL), we
achieved a further increase in luciferase accumulation with respect to luciferase expression in the
WT background. Importantly, near-wild type levels of functional Rubisco holoenzyme were
generated following the proteolytic removal of the fused luciferase, while luciferase activity for the
fusion protein was almost ~33 times greater than luciferase expressed alone. These data
demonstrate the utility of using fusion proteins to enhance recombinant protein accumulation in
algal chloroplasts, and also show that engineered proteolytic processing sites can be used to
liberate the exogenous protein from the endogenous fusion partner, allowing for the purification
of the intended mature protein.
Conclusion: These results demonstrate the utility of fusion proteins in algal chloroplast as a
method to increase accumulation of recombinant proteins that are difficult to express. Since
Rubisco is ubiquitous to land plants and green algae, this strategy may also be applied to higher plant
transgenic expression systems.
Published: 26 March 2009
BMC Biotechnology 2009, 9:26 doi:10.1186/1472-6750-9-26
Received: 24 September 2008
Accepted: 26 March 2009
This article is available from: http://www.biomedcentral.com/1472-6750/9/26
© 2009 Muto et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
Page 2 of 11
(page number not for citation purposes)
Background
The use of transgenic plant expression systems has
recently become of great interest to biotechnology, as
plants represent a potentially robust and economic plat-
form for recombinant protein production [1]. The use of
plants and green algal chloroplasts for transgenic protein
expression has some practical advantages compared to
that of nuclear expression. These advantages include the
absence of gene silencing, the ability to precisely target the
gene of interest to specific regions of the chloroplast
genome by homologous recombination, the potential for
robust expression of heterologous proteins, rapid genera-
tion of stable transgenic lines, simple promoter and
expression elements, and limited post-translational mod-
ifications to the recombinant protein [2-4]. Furthermore,
large-scale algal production can be undertaken in con-
tained facilities where the probability of environmental
spread of transgenes or product contamination is greatly
reduced compared to terrestrial plants grown in open
fields [3]. Thus far, chloroplast transformation has been
routinely employed only in tobacco and Chlamydomonas,
although chloroplast transformation has been reported
for several other plant species [5].
Expression of recombinant proteins in the Chlamydomonas
chloroplast is now well established [3], although expres-
sion levels vary considerably between proteins. The
Chlamydomonas chloroplast occupies a large proportion of
the cell volume (~60%), with sufficient capacity for signif-
icant exogenous protein accumulation [6,7]. Moreover,
methods for transforming the Chlamydomonas chloroplast
genome are relatively simple [8-10], and chloroplast
transformants can be selected through co-transformation
with DNA conferring resistance to antibiotics [11-13] or
through phototrophic rescue [10].
In order to achieve high levels of recombinant protein
expression in the C. reinhardtii chloroplast, codon-opti-
mized reporter genes were developed [14,15] and used to
examine a variety of promoter and translational elements
[16]. Using this strategy, GFP accumulation up to 0.5% of
total soluble protein (TSP) was achieved in transgenic
chloroplasts [15,16]. Although these expression levels
were sufficient for reporter gene measurements, overall
this level of protein expression is low relative to other pro-
tein expression systems. A synthetic luciferase gene, also
optimized to suit the C. reinhardtii chloroplast codon bias
(luxCt), was used to assay heterologous gene expression
under a variety of growth conditions [14]. Using the luxCt
gene, growth conditions for optimal gene expression in
chloroplast were successfully determined, but protein
accumulation of the LUXCt protein was again still mod-
est, at less than 0.1% TSP [14].
The rbcL gene, which encodes the ribulose bisphosphate
carboxylase/oxygenase large subunit (Rubisco LSU), may
present a unique strategic target for improving transgenic
protein accumulation in the chloroplast. The Rubisco LSU
promoter and translation elements have been used to
drive expression of exogenous reporter genes in C. rein-
hardtii [17], but expression using these elements alone did
not appear to be improved over other chloroplast promot-
ers and translation elements [16]. Kuroda and colleagues
made fusions of the first 14 N-terminal amino acids of
either the Rubisco LSU or ATP synthase β-subunit
(encoded by the atpB gene) to a neomycin phosphotrans-
ferase (NPTII) reporter enzyme and showed that silent
mutations made to the first 14 codons of the rbcL-NPTII
fusion caused a 35-fold decrease in NPTII accumulation,
whereas similar mutations to the atpB-NPTII  fusion
resulted in a less than 2-fold decrease in reporter protein
accumulation [18]. As the introduction of silent muta-
tions did not result in the creation of rare codons,
decreased reporter protein accumulation was attributed to
effects of mRNA sequences downstream of the translation
initiation codon on protein accumulation. Kasai et al.
have also demonstrated the utility of using the rbcL coding
region to increase expression of recombinant proteins
[19]. From such studies, it seems likely that mRNA
sequences downstream of the promoter/5' untranslated
region (UTR) contribute to the efficient translation of
some plastid mRNAs, although the precise role of these
elements remains elusive. Furthermore, it is tempting to
speculate that genetic fusions of efficiently-translated,
highly-abundant chloroplast proteins to an exogenous
protein of interest may represent an effective strategy for
high-level transgene expression. Since Rubisco is com-
monly noted to be the most abundant protein in photo-
synthetic organisms, recombinant protein fusions to the
chloroplast-encoded Rubisco LSU may potentially be
used to enhance the accumulation of poorly-expressed
recombinant proteins in the chloroplast. Fusion to
Rubisco LSU has already been reported for a small peptide
in tobacco [20]. Although fusion proteins have been used
successfully in many protein expression systems to
improve protein accumulation, this strategy has not been
attempted in the Chlamydomonas chloroplasts.
This study provides the first example of genetically manip-
ulating an algal photosynthetic protein to increase recom-
binant protein accumulation. By introducing an rbcL-
luxCt fusion gene we could show a substantial increase in
luciferase accumulation compared to expression of the
luxCt gene alone. Insertion of a proteolytic processing site
between the Rubisco LSU and LUXCt coding regions in
the fusion protein construct allowed for the generation of
separate Rubisco LSU and LUXCt proteins upon process-
ing by an endogenous chloroplast protease. We also dem-
onstrate that Rubisco LSU protein derived solely from the
fusion protein construct is completely functional, as evi-
denced by normal photosynthesis in transformants where
the endogenous rbcL  gene has been eliminated. SinceBMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
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Rubisco is ubiquitous to land plants and green algae, this
strategy may be potentially applied to other plant trans-
genic expression systems.
Results
Construction of the rbcL-luxCt fusion and rbcL-aphA6 
replacement genes in the C. reinhardtii chloroplast
To achieve high levels of heterologous protein expression
in the C. reinhardtii chloroplast, chimeric genes were
codon-optimized to reflect abundantly-expressed genes of
the  Chlamydomonas  chloroplast [14,15]. For luciferase
expression in the chloroplast, we first constructed the
expression cassette shown in Figure 1A, in which the
Chlamydomonas chloroplast luciferase reporter gene luxCt
[14], based on the bacterial luciferase AB gene of V. harveyi
[21] was ligated downstream of the rbcL promoter and 5'
UTR [16]. We had previously constructed the vector as an
internal standard for replacing the endogenous psbA gene,
thereby generating a non-photosynthetic strain, and
showed that expression of the luxCt reporter using this
rbcL promoter and 5' UTR achieved recombinant protein
accumulation to about 0.05% of total protein [7]. This
construct served as the standard for comparison with the
fusion proteins described below.
Maps of luxCt, rbcL-luxCt/rbcLwt, and rbcL-luxCt/rbcL- constructs for expression in C. reinhardtii chloroplasts Figure 1
Maps of luxCt, rbcL-luxCt/rbcLwt, and rbcL-luxCt/rbcL- constructs for expression in C. reinhardtii chloroplasts. A 
Schematic diagram of the replaced region, including relevant restriction sites. Homologous regions used for recombination 
between the insertion plasmid and the C. reinhardtii chloroplast genome are shown as flanking genome regions, and insert psbA 
sites in the chloroplast genome. B Map of the vector targeting the p322 inverted-repeat within the chloroplast. Relevant 
restriction sites delineate the rbcL 5' UTR (BamHI-NdeI), rbcL and luxCt coding regions, linker and preferredoxin transit peptide 
(preFd) regions, and the rbcL 3' UTR (XbaI-BamHI). Map showing the homologous region between the p322 plasmid and the C. 
reinhardtii chloroplast genome into which the chimeric rbcL-luxCt fusion gene was integrated. C. reinhardtii chloroplast DNA is 
depicted as the EcoRI to XhoI fragment of 5.7-kb located in the inverted repeat region of the chloroplast genome. C Transgene 
replacement of the endogenous rbcL gene through rbcL 5' and 3' homologous recombination (crossed lines) thereby knocking-
out the original rbcL coding region with the aphA6 kanamycin-resistance gene. The thick black lines indicate regions corre-
sponding to the probes used in the Southern and Northern blot analysis.BMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
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To determine if we could achieve higher levels of recom-
binant protein accumulation by fusing a recombinant
protein with a highly expressed endogenous protein, we
assembled the chimeric gene construct shown in Figure
1B. In this construct the luxCt gene was fused in frame and
downstream of the rbcL coding sequence with a 14 amino
acid linker (GS linker; GGGGSSGGGGGGSS) and a pre-
ferredoxin (preFd) enzymatic cleavage site between the
two genes [22]. The preFd enzymatic cleavage site was
chosen as a protease site that should be cleaved by the
endogenous preFd-processing enzyme normally found in
the chloroplast. This cleavage site provided the potential
to generate separate LUXCt and Rubisco LSU proteins fol-
lowing translation by site-specific cleavage of the fusion
protein at amino acid MAMAMRSTFAARVGAKPAVRGAR-
PASRMSCMA to generate two separate proteins. The
linker and processing sites were assembled from oligonu-
cleotides using the PCR-based method described previ-
ously [23]. PCR products were cloned into Escherichia coli
plasmids and ligated to generate the final fusion con-
struct. An NdeI site was placed at the rbcL initiation codon,
and an XbaI site was placed downstream of the luxCt stop
codon, to facilitate subsequent cloning steps. The rbcL-
luxCt fusion coding sequence was ligated downstream of
the rbcL promoter and 5' UTR, and upstream of the rbcL 3'
UTR (Figure 1B). The chimeric gene was then ligated into
the chloroplast transformation plasmid p322 [14,15] at
the unique BamHI site to create plasmid p322-rbcL-luxCt.
This construct was integrated into the p322 integration
site using a spectinomycin resistance selectable marker
gene as previously described [15].
To determine whether the Rubisco LSU protein was still
functional (as either the monomeric form generated by
preFd cleavage of the Rubisco LSU-LUXCt fusion protein
or as a fusion to the LUXCt protein), we constructed a
knock-out vector in which the endogenous rbcL gene in
strains expressing the rbcL-luxCt fusion could be deleted
by replacement of the endogenous rbcL gene with the kan-
amycin resistance selectable marker aphA6, as shown in
Figure 1C[12]. A codon-optimized aphA6 gene, driven by
the psbA promoter and 5' UTR, was ligated in place of the
coding region of the rbcL gene, but leaving 800 bp of
genomic sequence on the 5' end of the rbcL locus and 450
bp on the 3' end of the rbcL locus. These sequences were
retained to allow sufficient homology for integration of
the aphA6 gene as a direct replacement of the rbcL coding
region (Figure 1C). Since the Rubisco LSU-LUXCt fusion
protein provided the only source of Rubisco LSU in this
strain, we were able to determine whether rbcL-luxCt was
processed to restore Rubisco function by growing these
strains photoautotrophically.
Model of the Rubisco LSU-luciferase fusion protein
The structure of the Rubisco LSU-LUXCt fusion protein
was modeled (Figure 2) using the CHIMERA program
(University of California San Francisco) and the data from
the Protein Data Bank (PDB) public database. The struc-
ture of a Rubisco LSU-LUXCt fusion protein monomer
(Figure 2A) and tetramer (Figure 2B) were predicted. The
primary and tertiary structures of Rubisco LSUs were
found to be highly similar between C. reinhardtii and
other species [24]. The GS linker and preFd protease site
[25] that bridge the Rubisco LSU [24] and the LUXCt pro-
tein are estimates based on their relative size compared to
LUXCt and Rubisco LSU proteins [26,27]. As shown in
Figure 2, cleavage of the preFd protease site should leave
the Rubisco LSU with a short GS linker peptide on the car-
boxy terminus external to the protein, which is predicted
to have little impact on Rubisco holoenzyme assembly or
enzymatic function.
Transformation and integration of rbcL-luxCt and rbcL-
aphA6 genes into C. reinhardtii chloroplasts
Wild-type (WT) C. reinhardtii cells were transformed with
the p322-rbcL-luxCt  plasmid and the selectable marker
plasmid p228, conferring resistance to spectinomycin
Model of Rubisco LSU-LUXCt fusion protein structure Figure 2
Model of Rubisco LSU-LUXCt fusion protein struc-
ture. A Predicted structure of a Rubisco LSU-LUXCt mono-
mer. The GS linker (green) and preferredoxin protease site 
(preFd; purple) bridge the Rubisco LSU (blue) and a LUXCt 
(yellow). B Tetramer structure of the Rubisco LSU-LUX 
fusion.BMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
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[13,28]. Primary transformants were screened by South-
ern blot analysis, and positive transformants were taken
through additional rounds of selection to isolate homo-
plasmic lines in which all copies of the chloroplast
genome contained the integrated luxCt gene. A homoplas-
mic rbcL-luxCt transformant, still containing the wild type
copy of the rbcL gene, rbcL-luxCt/rbcLwt, was selected for
further experiments.
The rbcL-luxCt/rbcLwt fusion line was subsequently trans-
formed with the rbcL-aphA6 plasmid to generate the rbcL-
luxCt/rbcL- line, and transformants were selected on kan-
amycin plates. Integration of the recombinant genes and
replacement of the endogenous rbcL gene were confirmed
by Southern blot analysis (Figure 3A). The rbcL-luxCt and
rbcL-aphA6  constructs with relevant restriction sites are
indicated in Figure 1. Correct integration of the plasmid
p322-rbcL-luxCt into the chloroplast genome was ascer-
tained using probes to both the luxCt coding region and
the BamHI-XhoI fragment of plasmid p322. Replacement
of the endogenous rbcL gene was confirmed using probes
to both the aphA6 and rbcL coding regions (Figure 3A).
Genomic DNA from WT, rbcL-luxCt/rbcLwt and rbcL-luxCt/
rbcL-  lines was digested with restriction enzymes and
hybridized with the nucleotide probes according to the
figure legend. Both rbcL-luxCt/rbcLwt and rbcL-luxCt/rbcL-
transformants show a luxCt  hybridizing band at the
expected size of 4.4-kb, while the WT strain shows no sig-
nal with the luxCt probe (Figure 3A, third panel from left).
Additionally, only the rbcL-luxCt/rbcL- transformant pro-
duced an aphA6 hybridizing band (2.7-kb; Figure 3A, sec-
ond panel from left). Hybridization with the Bam HI-Xho
I fragment from the p322 plasmid identifies a single 5.7-
kb band in WT and a 3.4-kb band in the two transform-
ants, and all bands are of the expected size (Figure 3A, left
panel). Using an rbcL probe, a 4-kb band was detected in
WT and the rbcL-luxCt/rbcLwt transformant, produced from
the endogenous rbcL  gene, while the rbcL-luxCt/rbcLwt
transformant also contained a 3-kb rbcL hybridizing band
from the rbcL-luxCt gene (Figure 3A, right panel). The rbcL-
luxCt/rbcL- strain contained the 3-kb rbcL band from the
fusion protein and no endogenous rbcL  band at 4-kb.
These data demonstrate that the two transgenic lines are
homoplasmic for the correctly integrated rbcL-luxCt and
Southern and Northern blot analysis of rbcL-luxCt fusion (rbcL-luxCt/rbcLwt) and combined rbcL-luxCt fusion endogenous rbcL  knock-out (rbcL-luxCt/rbcL-) strains Figure 3
Southern and Northern blot analysis of rbcL-luxCt fusion (rbcL-luxCt/rbcLwt) and combined rbcL-luxCt fusion 
endogenous rbcL knock-out (rbcL-luxCt/rbcL-) strains. Lane 1, untransformed wild type (WT); lane 2, rbcL-luxCt fusion 
transformant rbcL-luxCt/rbcLwt; lane 3, combined rbcL-luxCt fusion/rbcL knock-out transformant (rbcL-luxCt/rbcL-). A C. reinhardtii 
DNA was digested with EcoRI and XhoI, and hybridized with the Bam-Xho probe (left panel), BamHI for aphA6 (second panel 
from the left) or lux probes (third panel from left), and EcoRI and BamHI for rbcL probes (right panel), respectively. B Detec-
tion of luxCt and rbcL mRNA expression in transgenic C. reinhardtii transformants. Total RNA isolated from WT, rbcL-luxCt/
rbcLwt, and rbcL-luxCt/rbcL- was separated on denaturing agarose gels (left panel) and blotted onto nylon membrane. The mem-
branes were hybridized with luxCt (middle panel) or rbcL (right panel) cDNA probes.BMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
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aphA6 transgenes, and the rbcL-luxCt/rbcL- strain is lacking
the endogenous rbcL coding region.
Accumulation of luxCt mRNA in transgenic strains
To determine if the luxCt gene was transcribed in trans-
genic C. reinhardtii chloroplasts, Northern blot analysis of
total RNA was used. Twenty micrograms of total RNA, iso-
lated from WT and the two transgenic strains, was sepa-
rated on denaturing agarose gels and blotted onto nylon
membranes. Duplicate filters were stained with methyl-
ene blue (Figure 3B, left panel), or hybridized with a 32P-
labeled luxCt probe (Figure 3B, middle panel), or rbcL
probe (Figure 3B, right panel). The rbcL probe identified
a 1.5-kb rbcL mRNA transcript produced from the endog-
enous rbcL gene in both the WT and in the rbcL-luxCt/
rbcLwt transgenic strain, but not in the rbcL replacement
strain  rbcL-luxCt/rbcL-  (lower bands; Figure 3B, right
panel). A larger transcript corresponding to the rbcL-luxCt
chimeric mRNA was identified in the both the rbcL-luxCt/
rbcLwt and rbcL-luxCt/rbcL- strains (upper bands; Figure 3B,
right panel), but not in WT. Hybridization of the filters
with the luxCt probe identified the chimeric rbcL-luxCt
mRNA of the predicted 4.3-kb in both the rbcL-luxCt/
rbcLwt and rbcL-luxCt/rbcL- lines, while no luxCt signal was
observed in WT (Figure 3B, middle panel). These data
confirm that the transgenic lines generated are producing
the expected rbcL and rbcL-luxCt mRNAs.
Accumulation and processing of the Rubisco LSU-LUXCt 
fusion protein yields individual Rubisco LSU and LUXCt 
proteins of the expected molecular weights
Western blot analysis of the different transgenic lines was
used to analyze the accumulation of both processed and
unprocessed Rubisco LSU and LUXCt proteins. Ten micro-
grams of total protein from WT, luxCt-expressing, and
from the rbcL-luxCt/rbcLwt, and rbcL-luxCt/rbcL-  fusion
strains was separated by SDS-PAGE and either stained
with Coomassie blue or blotted onto nitrocellulose filters
and hybridized with anti-Rubisco or anti-LUXAB antise-
rum. The Coomassie staining (Figure 4, left panel) indi-
cated that equal amounts of protein (10 μg) were loaded
in each lane, and that the transgenic lines accumulate a
similar set of proteins as compared to WT. Western blot
analysis of the same samples identified a 78-kDa band,
corresponding to the cleaved LUXCt protein, in all of the
luxCt transgenic lanes (Figure 4, middle panel). The anti-
LUXAB antibody also identified a Rubisco LSU-LUXCt
fusion protein (~133-kDa) in rbcL-luxCt/rbcLwt and rbcL-
luxCt/rbcL- transgenic strains. No signal was observed in
the WT C. reinhardtii lane, as expected. The same samples
were also assayed for Rubisco protein accumulation by
Western blot analysis (Figure 4, right panel). A mono-
meric or cleaved Rubisco LSU protein (approximately 55-
kDa) was identified in WT and all of the transgenic lines.
Moreover, an additional Rubisco LSU-LUXCt fusion pro-
tein (133-kDa) was identified in rbcL-luxCt/rbcLwt  and
rbcL-luxCt/rbcL- transgenic strains.
Analysis of luciferase activity in transgenic C. reinhardtii 
chloroplasts
To determine whether recombinant protein expression
differed between transgenic lines, luciferase activity was
measured by luminescence assays using a CCD camera.
For luciferase activity assays, 1 × 106 cells from WT and
each of the transgenic lines were spotted onto solid Tris-
acetate-phosphate (TAP) media. The plates were exposed
to decanal, the substrate for LUXCt, and luciferase activity
was measured using a CCD camera and Night Owl quan-
tification software. As shown in Figure 5, the WT cells have
no detectable luminescence signal, as expected. The
LUXCt control strains, luxCt driven by the rbcL or psbA
promoter and UTR (rbcL-luxCt  and  psbA-luxCt  strains),
show lower luciferase activity compared to LUXCt fusion
strains at this cell density (Figure 5, top panel and CCD
counts). Luciferase activity for the Rubisco LSU-LUXCt
fusion protein is at least 4.7 times greater than for the
LUXCt protein alone, and this increased luciferase activity
is seen in both the rbcL-luxCt/rbcLwt and the rbcL-luxCt/
rbcL-  strains (Figure 5, top panel and CCD counts).
Although the rbcL-luxCt/rbcL- strain produced the highest
luminescence signal (Figure 5, middle panel), the trans-
genic lines appear similar to WT cells when visualized
under reflective light (Figure 5, bottom panel).
Discussion
This study provides the first example of genetically manip-
ulating an endogenous chloroplast protein to increase
recombinant protein accumulation in algae. By introduc-
ing an rbcL-luxCt fusion gene we could increase activity of a
recombinant luciferase protein up to 140-fold compared to
the luciferase gene expressed alone, and ~33 times better
than the best previous promoter/UTR combination [7].
As recombinant proteins fused to endogenous proteins
are generally of little or no industrial or clinical use, we
chose a fusion strategy in which we engineered the desired
recombinant protein (LUXCt) to be cleavable from an
endogenous chloroplast protein (Rubsico LSU). To
accomplish this, we incorporated the 32 amino acid N-
terminal chloroplast transit peptide of the nuclear-
encoded preFd protein, an amino acid sequence known to
be proteolytically removed from preFd upon transloca-
tion of the protein into the chloroplast [22,29]. Using this
strategy, we demonstrate the production of a full-length
Rubisco LSU-LUXCt fusion protein capable of undergoing
in vivo proteolytic processing to yield: 1) a biologically-
active, mature LUXCt recombinant protein 2) a Rubisco
LSU monomer able to incorporate into the multi-subunit
Rubisco holoenzyme and support photoautotrophic
growth.BMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
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We further show that by expressing the fusion construct in
an rbcL knock-out background, LUXCt protein activity is
greatly enhanced relative to its expression in an rbcL WT
background. We suspect that by making the fusion pro-
tein the sole source of Rubisco LSU for incorporation into
the Rubisco holoenzyme, the transgene is more highly
expressed and thus LUXCt is more highly expressed.
Taken together, our data suggest that the forced expression
of a transgenic protein in the form of fusion to an endog-
enous protein required for photoautotrophic growth rep-
resents a novel strategy for the increased accumulation of
a recombinant protein in the chloroplast of the unicellu-
lar green algae C. reinhardtii.
Although we observed in vivo processing of LUXCt from
Rubisco LSU, the percent effective processing as judged by
western blot analysis is quite different when comparing
Rubisco LSU to LUXCt (Figure 4, far right panel). Exami-
nation of Figure 4 shows that Rubisco LSU is predomi-
nantly processed to the mature length, while examination
of LUXCt accumulation shows that only about 20% is
processed to the mature size. This suggests that processing
of the protein yields a stable Rubisco LSU and an unstable
LUXCt, which is then degraded. Although western blot-
ting indicates that the rbcL-luxCt/rbcLwt and the rbcL-luxCt/
rbcL- strains each produce 3–5 times more LUXCt than the
psbA-luxCt strain, LUXCt activity is ~33 times higher in the
rbcL-luxCt/rbcL- strain compared to the psbA-luxCt strain.
This suggests that LUXCt must be much more active when
expressed as a fusion protein in an endogenous rbcL
knock-out background.
The world-wide demand for clinically and industrially-rel-
evant recombinant proteins continues to grow, as does
the requirement to produce such proteins in a cost-effec-
tive manner at ever-increasing amounts. Since the advent
of recombinant DNA technology, several biological sys-
tems have been harnessed to produce recombinant pro-
teins, including bacteria, yeast, mammalian and insect cell
culture, and higher plants. While the success of large-scale
Detection of LUXCt protein accumulation in transgenic C. reinhardtii strains Figure 4
Detection of LUXCt protein accumulation in transgenic C. reinhardtii strains. Ten or two micrograms of total pro-
teins from untransformed wild type (WT), rbcL-luxCt fusion transformant (rbcL-luxCt/rbcLwt), combined rbcL-luxCt fusion/rbcL 
knock-out transformant (rbcL-luxCt/rbcL-), and the luxCt expressing strains, luxCt and psbA-luxCt, were separated by 12% SDS-
PAGE and stained with Coomassie blue (left panel), or blotted onto nitrocellulose membranes and decorated with anti-LUXAB 
(middle panel) or anti-Rubisco (right panel) antibodies. Protein levels from these strains were compared to a strain expressing 
LUXCt from the p322 integration site. Proteins were visualized on Western blots by alkaline phosphatase activity staining. Pro-
teins were derived from cultures grown on TAP.BMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
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production of recombinant proteins of medicinal value
(e.g. insulin, antibodies, growth hormone) using bacterial
and mammalian cell culture systems can not be refuted,
such systems are not without their disadvantages. Bacte-
rial expression is limited by the types of eukaryotic pro-
teins that can be expressed at high levels while
maintaining solubility, proper folding, and the correct
post-translational modifications. Production of recom-
binant proteins in mammalian cell culture, most notably
the Chinese hamster ovary [30] expression system,
addresses many of the problems that plague bacterial sys-
tems. Although such mammalian cell culture systems are
highly efficacious at producing properly-folded, correctly-
modified eukaryotic proteins, they have several draw-
backs: high initial and fixed operating costs, slow tempo-
ral progression from drug lead to large-scale production,
susceptibility to viruses and contamination by fungi and
bacteria. Clearly, there remains a significant need for a
recombinant protein expression platform that combines
the versatility of mammalian cell culture and the cost-
effectiveness of bacterial systems with several other
attributes lacking in both technologies.
Recombinant protein expression in the unicellular green
algae C. reinhardtii, has now been demonstrated for sev-
eral proteins of both prokaryotic and eukaryotic origin
[3]. Proteins expressed in this alga have been shown to
have biological activity equivalent to their native counter-
parts, demonstrating the efficacy of algae for producing
functional exogenous proteins [7]. C. reinhardtii is a very
attractive biological system for the large-scale production
of medicinally and industrially-relevant proteins for sev-
eral reasons. It is inexpensive to grow, free of invading
viruses, has easily transformed nuclear and chloroplast
genomes and can be grown photoautotrophically, elimi-
nating the need for a carbon source in the growth
medium, thereby limiting contamination of the algal cul-
ture.
The chloroplast is a unique environment for the produc-
tion of recombinant proteins as the chloroplast contains a
variety of chaperones [31,32] and protein disulfide iso-
merases [33] that allow for the correct folding of complex
mammalian proteins, yet the chloroplast lacks the ability
to perform several post-translational protein modifica-
tions in mammalian systems, such as glycosylation. How-
ever, there are a number of circumstances when post-
translational modifications are not desirable, and chloro-
plasts appear to be an ideal system to make proteins of
this type. Algal chloroplasts also appear to lack gene
silencing mechanisms (e.g. RNAi, miRNA-mediated gene
silencing) and transgenes introduced into the chloroplast
genome appear to be quite stable [3]. Although C. rein-
hardtii has many attributes that make it both suitable for
recombinant protein expression and superior to current
methodologies for the production of certain proteins,
achieving routinely robust transgene expression in the
algal chloroplast is not commonplace.
Genetic engineering of the C. reinhardtii chloroplast repre-
sents a promising strategy to address the issues of cost,
scalability and adaptability faced by current expression
methodologies, but only if robust recombinant protein
expression can be achieved. Several strategies have been
employed, by our laboratory and others, to increase the
accumulation of recombinant proteins in C. reinhardtii
chloroplasts. Codon optimization resulted in an up to 80-
fold increase in recombinant protein accumulation
[14,15,34], while a combinatorial analysis of a variety of
endogenous promoters and untranslated regions identi-
fied a variety of expression levels, some up to ten times
better than others [16]. Finally, replacing the endogenous
psbA gene with a chimeric gene containing the psbA pro-
moter and 5' UTR fused to a mammalian coding region
result in very high levels of expression of that particular
mammalian protein, approaching 10% of the TSP [7];
Quantification of luciferase in luxCt transgenic lines Figure 5
Quantification of luciferase in luxCt transgenic lines. 
Equal cell numbers of WT and luxCt transgenic lines (luxCt, 
psbA-luxCt, rbcL-luxCt/rbcLwt, and rbcL-luxCt/rbcL-) were spotted 
on solid Tris-acetate-phosphate (TAP) media. The samples 
were treated with a decanal and visualized on a CCD camera 
for luminescence (middle panel) or photographed under 
reflective light (bottom panel). The mean values (n = 4) of 
CCD counts were reported as total counts per second per 
sample. CCD counts were acquired and the highest value set 
to 100%. Relative values were calculated as a percentage of 
the highest value. The mean values (n = 4) ± SE were pre-
sented (top panel).BMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
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however, other recombinant proteins expressed at much
lower levels using the exact same chimeric promoter/5'
UTR. Highly-variable recombinant protein expression is
found in all expression systems, including bacterial and
mammalian cell culture. Some proteins with problematic
expression characteristics in bacterial systems show a dra-
matic increase in accumulation when the recombinant
protein is expressed as a fusion with a protein previously
shown to express at high levels in the bacterial system, and
hence we followed this strategy with the abundant endog-
enous Rubisco LSU protein in chloroplasts.
Analysis of transcription rates of chimeric constructs using
a beta-glucuronidase (GUS) reporter driven by various
endogenous 5' promoter/UTR elements revealed a possi-
ble interdependence between the rbcL 5' leader region and
the first 257 bp of the rbcL coding sequence [17]. In our
previous studies, we constructed chimeric mRNAs utiliz-
ing the 5' UTR/promoter and 3' UTR elements derived
from several endogenous chloroplast genes (e.g. rbcL,
atpA, psbA, psbD) to drive the expression of different exog-
enous coding regions including GFP, LUXCt and bovine
mammary serum amyloid albumin (M-SAA) [7,14-16].
For each transgene studied, we achieved good accumula-
tion of the transgenic mRNA, often mirroring the steady-
state levels of the endogenous transcript, but recombinant
protein accumulated to much lower levels than did the
endogenous proteins regulated by the same promoters
and UTRs. Indeed, there is evidence to suggest that tran-
script abundance is not limiting for protein synthesis of C.
reinhardtii chloroplast-encoded genes [35].
Conclusion
These results demonstrate the utility of fusion proteins in
the C. reinhardtii chloroplast as a means to increase accu-
mulation of recombinant proteins that are difficult to
express. It will be interesting to more rigorously test our
expression system by fusing other hard-to-express pro-
teins downstream of rbcL, express them in the rbcL knock-
out background and determine how broad the applicabil-
ity of our system is. It is possible that our expression strat-
egy will succeed beyond LUXCt production and that a
wide variety of recombinant proteins might be expressed
at high levels using this cleavable fusion strategy. While
this awaits further experimentation, the results of our
work are encouraging and suggest that expressing recom-
binant proteins in the form of cleavable fusions to highly-
expressed, endogenous chloroplast proteins might be a
robust platform by which recombinant proteins can be
produced in algal chloroplasts.
Methods
Chlamydomonas reinhardtii strains, transformation, and 
growth conditions
Transformations were carried out on C. reinhardtii strain
wild type (WT) 137c (mt+). Cells were grown to late log
phase (approximately 7 days) in the presence of 40 mM 5-
fluorodeoxyuridine in liquid TAP medium [36] at 23°C
under constant illumination of 3000 lux on a rotary
shaker set at 100 r.p.m. Fifty ml of cells was harvested by
centrifugation at 4000 g at 4°C for 5 min. The supernatant
was decanted, and cells were resuspended in TAP medium
at 0.5 × 108 cells/ml for subsequent chloroplast transfor-
mation by particle bombardment, as described previously
by Cohen et al. [8]. All transformations were carried out
under spectinomycin selection (150 μg ml-1) in which
resistance was conferred by co-transformation with plas-
mid p228 carrying a mutant allele of the 16S rRNA gene
which confers resistance to spectinomycin [13,28]. A
selectable marker gene aphA6, which confers resistance to
kanamycin, was used for the additional transformation
[12].
Construction of C. reinhardtii chloroplast vectors
All DNA and RNA manipulations were carried out essen-
tially as described previously [8,37]. The chloroplast
codon-optimized coding regions of the luxCt gene as well
as for the other recombinant proteins were synthesized de
novo according to the previous methods from a pool of
primers, each 40 nucleotides in length [14,22,23]. The 5'-
and 3'-terminal primers used in this assembly contained
restriction sites for NdeI and XbaI, respectively. The rbcL
promoter and 5' UTR and the rbcL 3' UTR fragments were
generated as described previously [15]. The vector con-
structed previously, eliminated photosynthesis by psbA
gene replacement [7], and was used as an internal stand-
ard for endogenous psbA gene deletion (Figure 1A). The
chloroplast transformation plasmid p322 was constructed
as described by Franklin et al. [15].
Southern and Northern blotting
Southern and Northern blotting procedures, as well as
32P-dCTP labeling methods in the generation of DNA
probes were carried out as described previously [8,37].
Radioactive probes used on Southern blots included the
2-kb luxCt coding region (lux probe as in Figure 1A), the
1.4-kb fragment from the rbcL cDNA coding region (rbcL
probe as in Figure 1A), and the 2.0-kb BamHI-XhoI p322
fragment (Bam-Xho probe as in Figure 1A). A 0.8-kb frag-
ment from the aphA6  coding region was also used to
detect aphA6 insertion (aphA6 probe as in Figure 1A). The
lux and rbcL probes were used to detect luxCt and rbcL
mRNA on Northern blots.
Recombinant protein expression, Western blotting, and 
luminescence assays
For whole-cell luminescence assays, C. reinhardtii cultures
were grown on solid TAP media under constant illumina-
tion (1000 lux) and the cells were resuspended in TAP
medium at 1 × 106 cells/10 μl for rbcL-luxCt/rbcLwt, and
rbcL-luxCt/rbcL- strains. A WT negative control strain and
two positive control strains luxCt (luxCt driven by rbcLBMC Biotechnology 2009, 9:26 http://www.biomedcentral.com/1472-6750/9/26
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promoter) and psbA-luxCt  (the  psbA  promoter driving
luxCt  expression replacing the endogenous psbA  locus)
were included. The cells were placed on solid TAP
medium, decanal was swabbed onto the plate lid, and the
cells were incubated for 5 min prior to visualization on a
CCD camera. The plate was visualized by luminescence
imaging using the Night Owl CCD camera, and total
luminescence was reported as counts per second per spot.
WT and recombinant strains of approximately equal cell
number were grown in TAP medium [36] at 23°C under
constant illumination of 1000 lux on a rotary shaker set at
100 r.p.m. As a positive control, protein from a LUXCt
expressing strain [7], luxCt, was immunoblotted for
LUXCt and Rubisco expression. For Western blot analysis,
proteins were isolated from C. reinhardtii utilizing a buffer
containing 750 mM Tris-HCl (pH 8.0), 15% sucrose (w/
v), and 100 mM β-mercaptoethanol. Total proteins from
C. reinhardtii were used in Western blot analysis. Western
blotting procedures were carried out as described previ-
ously [8] using rabbit anti-LUXAB (gift of Susan Golden)
and anti-Rubisco primary antibodies, followed by detec-
tion with an alkaline phosphatase-conjugated goat anti-
rabbit secondary antibody (Sigma, St Louis, MO, USA).
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